Sign in

CIK 0001750284

  • Non-accelerated filer
  • Smaller reporting company

Olema Oncology, Inc.

Sign in to watch
Ticker
OLMA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
300409740
Phone
+1 415-651-3316
Business address
365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
Former names
Olema Pharmaceuticals, Inc.
  1. 4 Open-market sale CHIEF BUSINESS OFFICER sold 5,251 shares at $29.38 ($154,274)
  2. 4 Open-market sale PRESIDENT AND CEO sold 3,044 shares at an average $30.01 ($91,353)
  3. 4 Open-market sale PRESIDENT AND CEO sold 871 shares at $30.05 ($26,174)
  4. 4 Open-market sale CHIEF TECHNOLOGY OFFICER sold 12,000 shares at $24.97 ($299,640)
  5. 4 Open-market sale CHIEF BUSINESS OFFICER sold 5,251 shares at an average $25.71 ($134,979)
  6. 4 Open-market sale CHIEF TECHNOLOGY OFFICER sold 12,000 shares at an average $25.10 ($301,258)
  7. 4 Open-market sale CHIEF BUSINESS OFFICER sold 5,251 shares at an average $26.51 ($139,191)
  8. 4 Open-market sale CHIEF TECHNOLOGY OFFICER sold 12,000 shares at an average $24.80 ($297,626)
  9. 4 Open-market sale CHIEF BUSINESS OFFICER sold 5,251 shares at an average $29.72 ($156,071)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Other acquisition Director acquired 99,556 shares (other)
  18. 4 Open-market sale CHIEF BUSINESS OFFICER sold 57,763 shares at an average $24.15 ($1,394,769)
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 10 of 13 · 244 filings